Skip to content

Public FDA record

Z-2151-2024: Centrella Max - The Centrella Smart+ Bed is intended for use in healthcare environments as a patient supp

Recall record Z-2151-2024 for Baxter Healthcare Corporation. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2151-2024
Company in FDA record
Baxter Healthcare Corporation
FDA classification date
Jun 14, 2024
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

There is a potential for the top cover of the hospital bed mattress to delaminate as a result of improper cleaning and lack of adequate details on the appropriate use of cleaning agents containing bleach.

Source facts

Action
The recalling firm issued letters on and dated 5/8/2024 via first class mail. The letter described the problem, listed the affected products, the hazard involved, and the actions to be taken by the customers. The actions informed the consignee of the following: (1) If bleach is occasionally used (for example as a disinfection against Clostridium difficile), remove any disinfectant residue prior to and after the use of bleach with a new or clean cloth soaked in tap water. Ensure all staff are trained in the protocol for the use of bleach during daily cleaning and as part of reprocessing between patients, by not using bleach as your primary cleaner/disinfectant. (2) If you have the affected product, identify if the top cover is damaged by examining for signs of abrasions, cuts, tears, or fluid ingress. Photographs are embedded in the letter showing a top cover with no damage and a top cover with damage. If top cover damage is identified, discontinue the use of that mattress. If damage is due to the use of bleach, a replacement will be arranged per step 3 below. (3) Contact Baxter Healthcare Center for Service to report any damaged or delaminated mattress covers. The phone number is provided and the hours of operation. (4) If you received this communication directly from Baxter, please acknowledge receipt of this notification by responding on our customer portal at https://BaxterFieldActionCustomerPortal.onprocess.com, even if you do not have any remaining inventory. Log in to the portal using the account number listed in the enclosed reply form instruction sheet. Acknowledging receipt of this notification will prevent you from receiving repeat notices. If you do not complete the acknowledgment, you will receive a phone call from OnProcess Technology on behalf of Baxter to confirm your receipt of this notification. (5) If you purchased this product from a distributor or wholesaler, please note that responding on the Baxter customer portal is not applicable. I
Initiated
2024-05-08
Root cause
Error in labeling
Distribution
Distribution was made nationwide. There was also government/military distribution. Foreign distribution was made to Australia, Canada, China, Japan, Qatar, Saudi Arabia, Singapore, Taiwan, Turkey, and United Arab Emirates.
Recall number
Z-2151-2024
Recall status
Open, Classified
CDRH record ID
207675
FDA classified
2024-06-14
Recall event number
94600

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗